help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on January 25, 2005
Journal of Clinical Endocrinology & Metabolism, doi:10.1210/jc.2004-1374
A more recent version of this article appeared on April 1, 2005
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
90/4/2076    most recent
Author Manuscript (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by JOHANNSEN, T. H.
Right arrow Articles by FOREST, M. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by JOHANNSEN, T. H.
Right arrow Articles by FOREST, M. G.
Right arrowPubmed/NCBI databases
*Substance via MeSH
*Genetics Home Reference
Hazardous Substances DB
*MENOTROPINS

Submitted on July 14, 2004
Accepted on January 18, 2005

Delayed Diagnosis of Congenital Adrenal Hyperplasia with Salt Wasting due to Type II 3{beta}-Hydroxysteroid Dehydrogenase Deficiency

TRINE H. JOHANNSEN*, DELPHINE MALLET, HARRIET DIGE-PETERSEN, JØ RN MÜLLER, KATHARINA M. MAIN, YVES MOREL, and MAGUELONE G. FOREST

University Department of Growth and Reproduction, GR-5064, Rigshospitalet, Blegdamsvej 9, DK-2100 Copenhagen, Denmark (T.H.J.; J.M.; K.M.M.); Laboratoire de Biologie Endocrinienne et Moléculaire, INSERM-EA3539, Hôpital Debrousse, 29 rue Soeur Bouvier, 69322 Lyon Cedex 05, France (D.M.; Y.M.; M.G.F.); and University Department of Clinical Physiological and Nuclear Medicine, Glostrup University Hospital, Nordre Ringvej, DK-2600 Glostrup, Denmark (H.D.-P)

* To whom correspondence should be addressed. E-mail: trinejohannsen{at}rh.dk.

Classical 3{beta}-hydroxysteroid dehydrogenase (3{beta}-HSD) deficiency is a rare cause of congenital adrenal hyperplasia (CAH). We report two sisters presenting with delayed diagnoses of classical 3{beta}-HSD, despite salt wasting (SW) episodes in infancy. Sibling 1 was referred for premature pubarche, slight growth acceleration and advanced bone age, while sibling 2 had no signs of virilization.

At referral, increased 17{alpha}-hydroxyprogesterone (17-OHP) associated with premature pubarche at first suggested a non-classical 21-hydroxylase deficiency. Sequencing of the CYP21 gene showed both girls only heterozygotes (V281L mutation). This result, combined with SW in infancy, suggested a 3{beta}-HSD deficiency because of increased DHAS levels. Further hormonal studies showed markedly elevated {Delta} (5)-steroids, in particular 17{alpha}-hydroxypregnenolone > 100 nmol/liter (the clue to the diagnosis) and elevated {Delta} (5)-/{Delta} (4)-steroid ratios. Sequencing of the type II 3{beta}-HSD gene documented that both girls were compound heterozygotes for T181I and 1105delA mutations. Retrospectively, elevated levels of 17-OHP were found on blood spots from Guthrie's test.

There is no previous report of the combination of SW and premature pubarche due to mutations in the type II 3{beta}-HSD gene. As neonatal diagnosis could have prevented life threatening crises in these girls, this report further supports the benefits for neonatal screening for CAH whatever the etiology.


Key words: 3{beta}-hydroxysteroid dehydrogenase deficiency • congenital adrenal hyperplasia • premature pubarche • salt loss







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2005 by The Endocrine Society